Related Experiment Video
Updated: Jun 29, 2026

Sleeve Gastrectomy in Mice using Surgical Clips
Published on: November 14, 2020
Sleeve gastrectomy leads to Helicobacter pylori eradication
Dean Keren1, Ibrahim Matter, Tova Rainis
1Gastroenterology Unit, Surgery Department, Bnai Zion Medical Center, Technion-Institute of Technology, Haifa, Israel. Dean.keren@b-zion.org.il
Helicobacter pylori (HP) infection is common in patients undergoing laparoscopic sleeve gastrectomy (LSG). Treating only symptomatic patients preoperatively resolved symptoms, suggesting LSG may aid HP eradication.
Area of Science:
- Gastroenterology
- Bariatric Surgery
- Microbiology
Background:
- The prevalence and impact of Helicobacter pylori (HP) in patients undergoing laparoscopic sleeve gastrectomy (LSG) remain unevaluated.
- HP infection is a significant factor in gastrointestinal health and disease.
Purpose of the Study:
- To investigate the role and prevalence of HP in patients before and after LSG.
- To assess the efficacy of HP eradication therapy in symptomatic patients undergoing LSG.
Main Methods:
- A 24-month study included obese patients undergoing LSG.
- Presurgical HP breath tests were conducted; symptomatic patients received triple therapy.
- Excluded stomachs were evaluated for HP post-surgery, with follow-up 13C-urea breath tests (UBT) for positive cases.
Main Results:
- Of 40 patients, 15 (37.5%) had presurgical HP; 11 symptomatic patients receiving therapy showed complete symptom resolution.
- HP was detected in 17 of 40 excluded stomachs (42.5%).
- Three months post-surgery, only three patients (17.6%) tested positive on 13C-UBT.
Conclusions:
- HP infection is frequent in patients undergoing LSG, but most follow-up tests were negative.
- Routine screening and treatment for all HP-positive LSG patients may be unnecessary.
- LSG might contribute to HP eradication, warranting further investigation into clinical implications.
Related Concept Videos
Peptic Ulcer Disease V: Surgical Management and Nursing Care
Surgical Interventions for Peptic Ulcer Disease
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Gastritis II: Pathophysiology
Gastritis III: Clinical Manifestations and Management
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Peptic Ulcer
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...